Loading clinical trials...

ACTIVE_NOT_RECRUITINGNA

Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients

Dépistage Des métastases cérébrales Par IRM Chez Les Patients Avec un adénocarcinome Colorectal métastatique

NCT03694938•Poitiers University Hospital

Summary

The aim of this study is to prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients using systematic annual screening by MRI.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with histologically proven colorectal adenocarcinoma
•Metastases from colorectal cancer diagnosed since less than 6 months
•Indication of an oncologic treatment

Exclusion Criteria

•Patient with contraindication for MRI
•Diagnosis of cancer other than colorectal cancer in the last three years, except in situ cancers, basal-cell skin cancer or squamous-cell skin cancer, and other cancer with low risk of brain dissemination according to the investigator
•Pregnant or breastfeeding women, women of childbearing potential without effective contraception

Locations (4)

C.H.U. d'Amiens

Amiens, France

Hôpital Privé Jean Mermoz

Lyon, France

C.H.U. de Poitiers

Poitiers, France

C.H.U. de Tours

Tours, France

Key Dates

Start Date

February 7, 2019

Primary Completion Date

February 1, 2030

Completion Date

February 1, 2030

Last Updated

July 20, 2025

Enrollment

143

ACTUAL participants

Conditions

Metastatic Colon Cancer

Interventions

Magnetic resonance imaging

DEVICE

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NCT07321106

Colorectal CancerColorectal Cancer (CRC)+5 more

View study

COMPLETEDNA

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

NCT05396807

Metastatic Colon Cancer

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients

Inclusion Criteria

Exclusion Criteria

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer

Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial

Hepatic Artery Infusion (HAI) Program at Duke University

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response